dihydrotestosterone

Preferred Label : dihydrotestosterone;

MeSH definition : A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.;

MeSH synonym : stanolone; 5-alpha-dht; androstanolone; 17beta hydroxy 5alpha androstan 3 one; 5 alpha dihydrotestosterone; 5 alpha-dihydrotestosterone; 5 alpha dht; 17beta-hydroxy-5alpha-androstan-3-one; 5-alpha dihydrotestosterone; dihydrotestosterone, 5-alpha;

CISMeF synonym : berenguer infale brand of androstanolone; Besins-Iscovesco brand of androstanolone; besins iscovesco brand of androstanolone; cuxson brand of androstanolone;

MeSH hyponym : gelovit; andractim; anaprotin;

Related MeSH term : dihydroepitestosterone; 5 beta-Dihydrotestosterone; 17 beta-Hydroxy-5 beta-Androstan-3-One; 5 beta Dihydrotestosterone; 17 beta Hydroxy 5 beta Androstan 3 One; beta-Hydroxy-5 beta-Androstan-3-One, 17;

MeSH CAS label : Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-;

MeSH Related Number : 521-18-6 (Dihydrotestosterone);

Registry Number MeSH : 521-18-6;

Wikipedia link : https://en.wikipedia.org/wiki/Dihydrotestosterone;

Codes EINECS : 208-307-3;

Is substance : O;

UNII : 08J2K08A3Y;

InChIKey : NVKAWKQGWWIWPM-ABEVXSGRSA-N;

Details

Origin ID

D013196;

UMLS CUI

C0038148;

ATC code(s)
- androstanolone [ATC Code]
ATC code(s)
- androstanolone [ATC Code]
- androstanolone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- dihydrotestosterone [Substance BNPC]
Currated CISMeF NLP mapping
- 5-alpha-dihydrotestosterone [SNOMED Notion]
- Androstanolone [LOINC component]
- Dihydrotestosterone (substance) [SNOMED CT concept]
- Stanolone [NCIt concept]
- Therapeutic Androstanolone [NCIt concept]
- androstanolone [SNOMED Notion]
Indexing information
- 1,2-seco-A-bis(norandrostan-17-ol)acetate [MeSH Supplementary Concept]
Pharmacological action(s)
- androgens [MeSH Descriptor]
Record concept(s)
- 17 beta-Hydroxy-5 beta-Androstan-3-One [MeSH concept]
- 5 beta-Dihydrotestosterone [MeSH concept]
- anaprotin [MeSH concept]
- andractim [MeSH concept]
- dihydroepitestosterone [MeSH concept]
- dihydrotestosterone [MeSH concept]
- gelovit [MeSH concept]
Related MeSH Supplementary Concept(s)
- 11-fluoro-19-nor-dihydro-testosterone [MeSH Supplementary Concept]
- 11-fluoro-dihydro-testosterone [MeSH Supplementary Concept]
- 16-fluorodihydrotestosterone [MeSH Supplementary Concept]
- 16-iodostanolone [MeSH Supplementary Concept]
- 17-(2-iodoethenyl)androsta-4,6-dien-17-ol-3-one [MeSH Supplementary Concept]
- 17-(2-iodoethynyl)androsta-4,6-dien-17-ol-3-one [MeSH Supplementary Concept]
- 17-(2-iodovinyl)dihydrotestosterone [MeSH Supplementary Concept]
- 17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one [MeSH Supplementary Concept]
- 17-N,N-diisopropylcarbamoyl-4-azaandrostan-3-one [MeSH Supplementary Concept]
- 17-epoxypropyldihydrotestosterone thiopropyl-sepharose [MeSH Supplementary Concept]
- 17-hydroxy-7-fluoro-17-methylandrostan-3-one [MeSH Supplementary Concept]
- 17-hydroxy-7-iodo-17-methylandrostan-3-one [MeSH Supplementary Concept]
- 17-hydroxyandrostan-19-ol-3-one [MeSH Supplementary Concept]
- 17-hydroxyandrostan-3-one 17-sulfate [MeSH Supplementary Concept]
- 17-ketotrilostane [MeSH Supplementary Concept]
- 18-hydroxy-18-methyl-16,17-methylene-D-homoandrostane-3-one [MeSH Supplementary Concept]
- 18F-MDHT [MeSH Supplementary Concept]
- 2,17-dimethyldihydrotestosterone [MeSH Supplementary Concept]
- 2-bromo-5-dihydrotestosterone [MeSH Supplementary Concept]
- 2-chloroethylnitrosocarbamoylalanine 17-dihydrotestosterone ester [MeSH Supplementary Concept]
- 3-(O-carboxymethyl)oximino-5-dihydrotestosterone [MeSH Supplementary Concept]
- 3-hydroxyandrostan-16-one [MeSH Supplementary Concept]
- 4,17-dimethyltrilostane [MeSH Supplementary Concept]
- 4,5-secodihydrotestosterone [MeSH Supplementary Concept]
- 5-dihydrotestosterone 3,17-bromoacetate [MeSH Supplementary Concept]
- 7-(O-carboxymethyl)oximino-5-dihydrotestosterone [MeSH Supplementary Concept]
- 7-alpha-fluoro-17 alpha-methyl-5-alpha-dihydrotestosterone [MeSH Supplementary Concept]
- 7-fluoromethyldihydrotestosterone [MeSH Supplementary Concept]
- 7-hemisuccinamido-5-dihydrotestosterone [MeSH Supplementary Concept]
- 7-iodo-17-hydroxy-3-androstanone [MeSH Supplementary Concept]
- L 751788 [MeSH Supplementary Concept]
- RB 346 [MeSH Supplementary Concept]
- androstan-3,17-diol-11-one [MeSH Supplementary Concept]
- androstan-3-one [MeSH Supplementary Concept]
- demalon [MeSH Supplementary Concept]
- dihydrotestosterone 17-bromoacetate [MeSH Supplementary Concept]
- dihydrotestosterone glucuronide [MeSH Supplementary Concept]
- dihydrotestosterone heptanoate [MeSH Supplementary Concept]
- dihydrotestosterone propionate [MeSH Supplementary Concept]
- dihydrotestosterone-17-N-bis(2-chloroethyl)carbamate [MeSH Supplementary Concept]
- mestanolone [MeSH Supplementary Concept]
- nitrostanolone [MeSH Supplementary Concept]
- stanolone benzoate [MeSH Supplementary Concept]
- testiphenon [MeSH Supplementary Concept]
- trilostane [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Dihydrotestosterone Measurement [NCIt concept]
- Mestanolone [ICD-11 Extension code]
- Product containing androstanolone (medicinal product) [SNOMED CT concept]
- dihydrotestosterone preparation [SNOMED Notion]
Semantic type(s)
- Hormone [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 5-alpha-dihydrotestosterone [SNOMED Notion]
- Androstanolone [LOINC component]
- Dihydrotestosterone [NCIt concept]
- Dihydrotestosterone (substance) [SNOMED CT concept]
- Product containing androstanolone (medicinal product) [SNOMED CT concept]
- Stanolone [NCIt concept]
- Therapeutic Androstanolone [NCIt concept]
- androstanolone [ATC Code]
- androstanolone [ATC Code]
- androstanolone [SNOMED Notion]
- dihydrotestosterone [Substance BNPC]
- dihydrotestosterone preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- androstanolone [ATC Code]
- androstanolone [ATC Code]
Validated automatic mappings to NTBT
- Dihydrotestosterone [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients